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Abstract
BACKGROUND & AIMS—Intestinal microbes induce homeostatic mucosal immune responses,
but can also cause inappropriate immune activation in genetically susceptible hosts. While
immune responses to bacterial products have been studied extensively, little is known about how
intestinal inflammation affects the function of commensal luminal microbes.
METHODS—Microarrays and real-time PCR were used to profile transcriptional changes in
luminal bacteria from wild-type (WT) and IL-10−/− (KO) mice monoassociated with a non-
pathogenic murine Escherichia coli isolate (NC101), which causes colitis in gnotobiotic KO mice.
Colonic inflammation, innate and adaptive immune responses were measured in WT and KO mice
monoassociated with mutant NC101 lacking selected upregulated genes and in KO mice co-
colonized with mutant and parental NC101. Intracellular survival of bacteria within primary
mouse macrophages and resultant TNF production was measured.
RESULTS—Significant upregulation of the stress response regulon, including the small heat
shock proteins IbpA and IbpB that protect E. coli from oxidative stress, was observed in bacteria
from KO mice with colitis compared to healthy WT controls. In KO mice, ibpAB expression
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resulted in reduced colonic histologic inflammation, secretion of IL-12/23p40 by colonic explant
cultures, serologic reactivity to NC101 antigens, and IFNγ secretion by stimulated mesenteric
lymph node cells. Infection of primary macrophages by bacteria expressing ibpAB was associated
with decreased intracellular survival and attenuated TNF secretion.
CONCLUSIONS—Chronic intestinal inflammation causes functional alterations in gene
expression of a commensal gut bacterium. Further studies of this component of the host-microbial
dialogue may identify potential novel therapeutic targets to treat inflammatory bowel diseases.
Keywords
Inflammation; Bacteria; Gene Expression
INTRODUCTION
Relative to higher-order, multicellular organisms, microbes are unique in their ability to
rapidly evolve with genetic adaptation to environmental conditions. Adaptation of non-
pathogenic commensal microbes, such as those residing in the lumen of the gastrointestinal
tract, occurs in response to host physiologic conditions. For instance, fucosylated glycans,
mucus, and antigen-specific sIgA have been shown to shape luminal bacterial gene
expression1–3. Although these studies indicate that the normal intestinal environment
influences the composition and function of the gut microbiota, the impact of specific disease
states on intestinal microbial communities is only now beginning to be explored.
A prevailing hypothesis is that inflammatory bowel diseases (IBD) are due to a combination
of genetic and environmental factors, which predispose to dysregulated immune responses
to the commensal intestinal bacteria4. Similar to human IBD, the intestinal microbiota is
important in the pathogenesis of chronic, immune-mediated experimental colitis4. For
instance, mice lacking the IL-10 gene (IL-10−/−) are healthy when raised in a germ-free (GF)
environment, but rapidly develop chronic, bacterial antigen-specific T-cell-mediated colitis
resembling IBD when transferred to specific-pathogen-free (SPF) conditions5, 6. The
inflammation in human IBD and experimental colitis is also characterized by increased
tissue levels of reactive oxygen (ROS) and nitrogen species7, 8.
While the intestinal microbiome is complex, preferential expansion of subsets of bacteria
including E. coli is associated with Crohn’s disease9, 10. Certain commensal E. coli that
adhere to and invade epithelial cells have been implicated in the development of ileal
Crohn’s disease11. Similarly, in animal models, selective colonization (monoassociation)
with a fecal murine isolate of non-pathogenic E. coli (NC101) for three weeks induces
histological evidence of colitis in ex-GF IL-10−/− mice but not in wild-type (WT) controls12.
This strain of E. coli exhibits many of the characteristics of adherent/invasive E. coli
isolated from Crohn’s disease patients, including persistence within macrophages
(unpublished data).
In addition to the expansion of select species of commensal bacteria such as E. coli, broad
shifts in the composition of the gut microbial communities are also associated with intestinal
inflammation in both human IBD and experimental colitis13. However, whether these
changes are primary or secondary is unknown nor is much known about how pathologic
inflammation affects the function of commensal intestinal microbes. We hypothesize that
the unique adaptive capabilities of commensal gut microbes allow them to respond to
intestinal inflammation by altering gene expression patterns that increase their survival and
virulence. Here we provide evidence that a gut commensal strain, E. coli NC101,
upregulates its stress response regulon in monoassociated IL-10−/− mice with colitis
compared to healthy controls. Furthermore, we show using deletion mutants that expression
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of two components of the E. coli stress response regulon, ibpA and ibpB, is associated with
decreased luminal growth, impaired intracellular macrophage survival, and diminished pro-
inflammatory host immune responses. These findings suggest that chronic, immune-
mediated intestinal inflammation upregulates a pathway in a commensal gut microbe that
ultimately proves to be detrimental to bacterial growth and persistence within macrophages
and, at the same time, attenuates the pro-inflammatory host response.
METHODS
Bacterial Strains, Lysates, and Growth Curves
The non-pathogenic murine E. coli strain designated NC101 was originally isolated from a
randomly-chosen colony from the feces of WT mice raised in SPF conditions12. The
Enterococcus faecalis (strain OG1RF) was originally obtained from a human oral isolate
kindly provided by Dr. Mark Huycke. NC101ΔibpAB was constructed using λ-red
recombinase and NC101ΔibpAB(pGEN-MCSibpAB) was constructed using standard
molecular biology techniques (Supplementary Methods). Bacterial lysates were prepared
from bacterial cultures grown in either LB or BHI media using mechanical disruption as
described elsewhere12. For growth curves, LB or BHI was inoculated with an overnight
bacterial culture and incubated at 37°C. The OD600 of the cultures was measured at the
indicated time points.
Isolation of Bone Marrow-Derived Macrophages
The murine fibroblast cell line, L929, was used as a source of M-CSF and was kindly
provided by Dr. Scott Plevy (UNC Chapel Hill, NC). Conditioned media from L929 cells,
was made as previously described14. Bone marrow-derived macrophages (BMDM) were
cultured from femurs and tibias of WT and IL-10−/− 129Sv/Ev mice as previously
described15.
Mice
GF IL-10−/− and WT control (both on the 129S6/SvEV background) were originally derived
in sterile conditions, by hysterectomy at the Gnotobiotic Laboratory (University of
Wisconsin Madison). Mice maintained in germ-free conditions at the National Gnotobiotic
Rodent Resource Center at UNC-Chapel Hill were monoassociated with bacteria by
swabbing the snout and anus (experiments lasting >10 days) or by oral gavage of 1 × 109
CFU (experiments lasting ≤10 days) with an overnight bacterial culture. Inoculums for dual-
association studies were prepared by mixing equal volumes of overnight cultures of NC101
and NC101ΔibpAB with same OD600 immediately prior to administration. Absence of
isolator contamination was confirmed by Gram stain and culture of cecal contents on sheep
blood agar or BHI plates under aerobic and anaerobic conditions. Animal use protocols were
approved by the UNC-Chapel Hill Institutional Animal Care and Use Committees.
RNA Isolation From Cecal Contents
Approximately 300mg of freshly-harvested cecal or transverse colon contents were snap
frozen in N2 (l) and stored at −80°C until ready for use. Frozen samples were thawed into
1mL of RNAProtect Bacteria Reagent (Qiagen) while vortexing, incubated at 25°C for 5
min, and bacterial RNA was isolated as described previously16.
Microarray Hybridization and Statistical Analysis
RNA samples were analyzed for purity and integrity on Agilent Bioanalyzer chips according
to the manufacturer’s instructions (Agilent Technologies). All E. coli RNA samples were
prepared for microarray hybridization according to the expression analysis technical manual
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from Affymetrix. Affymetrix E. coli Genome 2.0 arrays were washed and stained with the
Fluidics Station 450. The arrays were scanned with the GeneChip Scanner 3000 7G Plus
with Autoloader. Basic data analysis of the arrays was carried out with MAS 5.0 software to
generate intensity values for each gene. Statistical analysis of microarray results was
performed using GeneSpring 7.2 software. The list of normalized, differentially-regulated
genes was narrowed to those genes with statistically significant differences when grouped
by genetic characteristic (Welch t-test, p-value cutoff 0.05, multiple testing correction:
Benjamini and Hochberg False Discovery Rate).
Transcription factor, including initiation factor σ, binding sites were identified in promoter
elements of selected E. coli genes from the microarray results using the E. coli K-12
regulonDB 6.7 online database (http://regulondb.ccg.unam.mx/index.jsp)17.
Real-time PCR
Real-time oligonucleotide primers were designed using Applied Biosystems Primer Express
3.0 software based on E. coli MG1655 genomic DNA sequences published in Genbank
(Table S4). First-strand cDNA was synthesized from 1μg total RNA using M-MLV Reverse
Transcriptase (Invitrogen) per the manufacturer’s instructions. Two μL of the reaction were
added to 3.75 pmol of each primer and 2× SYBR Green PCR Master Mix (Applied
Biosystems) in a final volume of 12.5μL and analyzed in an ABI 7900HT thermocycler
using the manufacturer’s universal thermocycling conditions: 95°C for 10 minutes then 40
cycles of 95°C for 15 sec and 60°C for 60 sec. The specificity of amplification was
confirmed by melting curve analysis and agarose gel electrophoresis of PCR products. All
reactions were run in triplicate. Fold-change was calculated using the ΔΔCt method relative
to E. coli 16S rRNA.
Quantification of Luminal Bacteria
A small amount of cecal and mid-colonic luminal contents were collected into pre-weighed,
sterile tubes. Assuming that 1g of contents has a volume of 1mL, the samples were serially
diluted to 10−7, 10−8, and 10−9 in sterile phosphate-buffered saline (PBS). One-hundred μL
of each dilution were plated onto BHI agar and incubated at 37°C for 24 hours under aerobic
conditions. Results were expressed as colony forming units (CFU)/g of contents.
Histological Scoring
Sections of colon (proximal, transverse, distal) and cecum, were fixed in 10% neutral
buffered formalin for 24–48 hrs. The fixed tissue was embedded in paraffin, sectioned and
stained with hematoxylin and eosin (H&E). Individual sections were scored for severity of
inflammation by a single, blinded individual using a validated scale of 0–412. Where
indicated, a composite colonic inflammation score was obtained by summing the scores of
four individual colonic sections (cecum, proximal, mid, and distal colon) from each animal.
Western Blots
Fifteen μg/lane of NC101 lysate prepared as described above were resolved on a 10% SDS/
polyacrylamide gel, transferred to PVDF membrane, probed with 1:1000 dilution of mouse
serum in 5% dry milk-TBST for 90 min, washed 3 times in TBST, incubated with 1:5000
dilution of sheep anti-mouse IgG-HRP in 5% dry milk-TBST for 60 min, washed 3 times,
incubated with ECL-Plus (Amersham) for 5 min, and then exposed to X-ray film.
Colonic Tissue Fragment Cultures
Colonic tissue fragment cultures were prepared from the proximal colon as previously
described5, 12. Briefly, the colonic tissue fragments were washed with PBS then RPMI
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containing 50μg/mL gentamicin, blotted dry, and weighed. Fragments were placed into 1mL
of complete RPMI in 24-well plates, cut into pieces with scissors, and incubated for 20
hours at 37°C. Supernatants were collected and stored at −20°C.
Mesenteric Lymph Node Preparation and Culture
Mesenteric lymph nodes (MLN) were aseptically removed and single cell suspensions were
prepared by gentle disruption between sterile, frosted glass microscope slides. Cells were
washed and resuspended in RPMI with 10% FBS, 2mM L-glutamine, 1mM sodium
pyruvate, 0.05mM 2-mercaptoethanol, and penicillin (100U/ml)-streptomycin (100μg/ml). 5
× 105 cells/well in quadruplicate were stimulated with either media control, or NC101 or E.
faecalis lysates (5μg protein/mL) in 96-well plates (final volume of 0.2mL per well) for 72
hrs18. Culture supernatants were collected and stored at −20°C prior to cytokine
quantification.
Gentamicin Protection Assays
Bacterial uptake and survival within macrophages was measured as described previously19.
Briefly, approximately 10 bacteria/cell were added to BMDMs and incubated for 90 min and
then treated for 90 min with media containing 100μg/mL gentamicin. Supernatants were
removed and stored at −20°C for future cytokine analysis. In separate plates, after the initial
gentamicin treatment and washing, 20μg gentamicin/mL was added and plates were
incubated for an additional 23.5 hrs after which supernatants were removed and stored at
−20°C for future cytokine analysis. Survival ratios were calculated by dividing the numberof
bacteria detected after 24 hrs of gentamicin treatment by the number detected after 1.5 hrs of
gentamicin treatment.
Cytokine Measurements
To measure amounts of TNF secreted by infected BMDM, IFN-γ secreted by stimulated
MLN cells and IL-12/23 p40 secreted by colon tissue fragment cultures, we used
commercially available monoclonal anti-mouse TNF (Cat.No. 555268), IFN-γ (Cat.No.
551866), and IL-12/23 p40 (Cat.No. 555165)- specific capture and detection reagents (BD
Biosciences Pharmingen) in enzyme-linked immunosorbent assays (ELISAs) according to
the manufacturer’s protocols with the following exceptions: 1) five washes were performed
for all wash steps, and 2) for IL-12/23p40 ELISAs, we followed the TNF ELISA protocol,
but used IL-12/23 capture and detection reagents. Cytokine levels were measured in
duplicate supernatants and compared to standard curves generated using recombinant
murine cytokines per the manufacturer’s instructions.
Statistical Analysis
Microarray data were analyzed as described above. All other data are presented as the mean
± SEM. P values were calculated using the unpaired, 2-tailed Student’s T-test.
RESULTS
The Intestinal Inflammatory Milieu Induces Stress Response Genes in a Commensal E. coli
Strain
While the effects of bacterial products on intestinal immune responses are fairly well-
characterized, the impact of inflammation on commensal bacterial function is poorly
understood. We hypothesized that luminal bacteria adapt to chronic, immune-mediated
colitis by altering the expression of genes in a manner that promotes bacterial survival in a
hostile environment. To test this hypothesis, we monoassociated GF WT or IL-10−/− mice
with the non-pathogenic, commensal murine strain E. coli NC101, which was previously
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shown to cause a Th1/Th17-mediated colitis in IL-10−/−, but not WT, mice20. Consistent
with prior results, IL-10−/−, but not WT, mice had moderate histologic cecal inflammation 3
and 7 weeks post-colonization (Figure 1A). Similarly, innate immune responses, measured
by spontaneous secretion of IL-12/23p40 from colonic explant cultures, were increased in
IL-10−/− mice compared to WT mice colonized with NC101 (Figure 1B). Together, these
data confirm that NC101 induces moderate chronic inflammation in monoassociated
IL-10−/−, but not WT, mice.
We next performed transcriptional profiling of luminal bacteria isolated from the ceca from
colitic IL-10−/− and healthy WT mice monoassociated with NC101 for 7 weeks using
microarrays. Sixty-four genes were upregulated ≥1.5-fold and 150 genes were
downregulated ≥2-fold in NC101 from IL-10−/− mice with colitis compared to NC101 from
WT mice (Tables S1 & S2). In general, genes encoding enzymes of amino group and
butanoate metabolism were differentially regulated and TCA cycle-associated genes were
downregulated (Table S3). Interestingly, 27% of the identified upregulated genes are
involved in E. coli stress responses and many of the genes are transcribed by alternative σ
factors previously identified to control the E. coli stress response regulon (Table 1). Real-
time PCR results of selected upregulated genes confirmed the microarray results (Figure
S1). These data suggest that E. coli NC101 responds to chronic intestinal inflammation, in
part, by upregulating stress response genes. For example, acid tolerance genes (gadAB,
hdeAB, yhiX, evgA) are upregulated although pH of cecal contents is no different (data not
shown). Furthermore, some of the most highly upregulated genes (ibpB, ibpA, oxyS) have
been shown to protect bacteria from ROS21–24, which are increased in intestinal tissue of
patients with IBD and animals with experimental colitis7, 8.
Expression of Genes Encoding the Small Heat Shock Proteins IbpAB in E. coli Decreases
Bacterial Survival in vivo and Attenuates Experimental Colitis
Assuming bacteria upregulate stress responses during intestinal inflammation to survive, we
hypothesized that deletion of specific stress response genes from bacteria may decrease their
survival and virulence in the inflammatory milieu resulting in attenuated intestinal
inflammation. Specifically, since ibpA and ibpB (ibpAB) are among the most highly
upregulated stress response genes and have been shown to protect E. coli from ROS, we
predicted that these genes enhance the survival and virulence of NC101 in the intestine of
IL-10−/− mice with colitis. To test this hypothesis, we constructed a mutant strain of NC101
lacking ibpAB (NC101ΔibpAB) and measured growth rates and indicators of chronic,
immune-mediated colitis in monoassociated WT and IL-10−/− mice. Interestingly, while in
vitro growth of NC101 and NC101ΔibpAB was similar, luminal concentrations of
NC101ΔibpAB were significantly greater than NC101 in monoassociated WT and IL-10−/−
mice (Figure 2). We confirmed the absence of ibpAB expression in cecal bacteria from
NC101ΔibpAB-monoassociated IL-10−/− mice using real-time PCR (Figure S2). These
findings suggest that, contrary to our original hypothesis, expression of ibpAB in NC101
limits its growth in vivo independent of intestinal inflammation.
To determine whether in vivo survival differences between the two strains are associated
with differences in their colitogenic potential in IL-10−/− mice, we quantified colonic
inflammation in the two groups of mice. Increased bacterial density correlated with higher
cumulative colitis scores in IL-10−/− mice monoassociated with NC101ΔibpAB compared
to NC101 (Figures 3A&B).
Since others have demonstrated that enhanced humoral immune responses to microbial,
including E. coli, antigens in patients with Crohn’s disease correlates with a more aggressive
disease course25, we questioned whether increased inflammation in NC101ΔibpAB-
compared to NC101-monoassociated IL-10−/− mice was associated with increased levels of
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anti-E. coli antibodies. Indeed we found increased numbers and intensities of
immunoreactive bands on Western blots of NC101 lysate probed with sera from
NC101ΔibpABNC101-monoassociated IL-10−/− mice (Figure 3C).
IL-12 and IL-23 are produced by macrophages and dendritic cells when microbial products
bind to Toll-like receptors (TLRs), and promote the differentiation or expansion of effector
Th1 and Th17 cells, respectively, both of which participate in the development of chronic
colitis26, 27. To assess the role of mucosal innate immune responses in potentiating colitis in
NC101ΔibpAB-monoassociated IL-10−/− mice, we measured spontaneous secretion of
IL-12/23p40 in colonic explant cultures. Consistent with increased histologic inflammation,
colonic explants from NC101ΔibpAB-monoassociated IL-10−/− mice secreted more
IL-12/23p40 than those from NC101-monoassociated mice suggesting activation of innate
immune pathways (Figure 3D).
Since IL-12/23p40 effectively links the innate and the adaptive immune systems, we wanted
to determine whether the increased production of IL-12/23p40 observed in NC101ΔibpAB-
monoassociated mice is associated with enhanced bacterial antigen-specific adaptive
immune responses in these mice. To test this, we measured IFN- production by NC101
lysate-stimulated mesenteric lymph node (MLN) cells obtained from NC101ΔibpAB- and
NC101-monoassociated WT and IL-10−/− mice. Stimulated MLN cells from IL-10−/− mice
colonized with NC101ΔibpAB secreted more IFN- compared to those from mice colonized
with NC101 for both 3 and 5 weeks (Figure 3E). There were no significant differences in
IFN-γ secretion by MLN cells from the two groups of animals when stimulated with lysates
from an unrelated Gram positive bacterium, Enterococcus faecalis, and the amounts of
secreted IFN-γ were negligible (data not shown). Importantly, in IL-10−/− mice
monoassociated with a complemented strain of NC101ΔibpAB [NC101ΔibpAB(pGEN-
MCSibpAB)] for 3 weeks, luminal bacterial concentrations, histologic inflammation, and
IFN-γ secretion by stimulated MLN cells were similar to results obtained in NC101-
monoassociated IL-10−/− mice (Figure S3). Expression of ibpAB in luminal E. coli from the
NC101ΔibpAB(pGEN-MCSibpAB)-monoassociated mice was confirmed by real-time PCR
(Figure S2). Taken together, these results suggest that, contrary to our original hypothesis,
expression of ibpAB in E. coli is detrimental to luminal bacterial survival and attenuates
innate, and adaptive mucosal immune responses in both IL-10−/− and WT mice. However,
the mechanisms by which this occurs is unclear.
Decreased E. coli Survival Associated with ibpAB Expression Does Not Correlate with
Reduced Histologic Inflammation at Early Time Points
Since our initial observations indicated that ibpAB expression in NC101 is associated with
decreased bacterial growth and attenuated mucosal inflammation at later time points (≥3
weeks), we hypothesized that reduced mucosal inflammatory responses are due to impaired
luminal bacterial survival in NC101-monoassociated IL-10−/− mice rather than a direct
effect of ibpAB on the host immune system. To test this, we dual-associated IL-10−/− mice
with equivalent numbers of NC101 and NC101ΔibpAB to determine whether host
inflammatory responses correlated with the proportion of luminal NC101ΔibpAB or total
bacteria. At 5 weeks, there were similar numbers of luminal bacteria in NC101ΔibpAB-
monoassociated and dual-associated mice, and 82 ± 4.6% of cecal bacteria in dual-
associated mice were NC101ΔibpAB (Figure S4). Histologic inflammation and
IL-12/23p40 secretion from colonic explants were equivalent in the two groups of mice
suggesting that host inflammatory responses correlate better with total bacteria number than
with proportion of ibpAB-expressing bacteria (Figure S4). However, since the vast majority
of bacteria in the dual-associated mice were NC101ΔibpAB, we cannot exclude the
possibility that ibpAB expression may directly influence host immune responses
independent of luminal bacteria numbers.
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Next, we monoassociated IL-10−/− mice with NC101 or NC101ΔibpAB for shorter times (3
and 10 days) to determine whether differences in luminal bacterial concentrations at these
early time points correlate with differences in the degree of mucosal inflammation as they
had at later time points. NC101ΔibpAB grew to higher densities than NC101 in cecal and
transverse colon contents as early as 3 days after colonization, and this difference persisted
through five weeks in cecal contents, but decreased in magnitude in transverse colon
contents (Figures 4A and B). However, at 3 days, the difference in IL-12/23p40 secretion
from colonic explants, a measure of early inflammatory responses, and IFN- production by
NC101 lysate-stimulated MLN cells from the two groups of animals were still relatively
small, but statistically significant (Figures 4C & D). Moreover, there was no difference in
histologic inflammation at 3 and 10 days (Figure 4E). Thus, peak differences in luminal
bacterial concentrations between NC101 and NC101ΔibpAB occurred soon after
monoassociation, at a time when differences in measures of inflammation were minimal.
Though changes in inflammation may lag alterations in luminal bacterial concentrations,
these data suggest that the disparity in inflammation noted between NC101- and
NC101ΔibpAB-monoassociated IL-10−/− mice may not be entirely dependent on differences
in luminal bacterial concentrations of the two strains.
IbpAB Expression is Associated with Impaired Survival of E. coli NC101 in Murine
Macrophages
Since decreased growth of luminal NC101 compared to NC101ΔibpAB did not completely
correlate with decreased measures of inflammation, we wanted to determine whether ibpAB
expression affected bacterial clearance by innate immune cells. Others have shown that
adherent, invasive E. coli strains isolated from CD patients survive and replicate within the
phagolysosome of murine macrophages and that intracellular persistence in macrophages is
associated with constitutive secretion of TNF-α, a pro-inflammatory cytokine important in
the pathogenesis of CD28. We therefore hypothesized that ibpAB expression may reduce
intestinal inflammation in part by decreasing survival of NC101 within mucosal
macrophages resulting in decreased TNF secretion. To test this hypothesis, we performed
gentamicin protection assays using murine bone marrow-derived macrophages (BMDM) to
determine whether NC101 was more vulnerable to killing within macrophages compared to
NC101ΔibpAB, and if so, whether this correlated with decreased production of TNF by
macrophages. We found that expression of ibpAB influenced initial uptake of NC101 in
IL-10−/−, but not WT, macrophages by reducing the number of internalized bacteria at 1 hr
(Figure 5A). However, once internalized, NC101ΔibpAB survived better in macrophages
from both mouse backgrounds at 24 hrs than did NC101 (Figure 5A & B). Furthermore,
while there was no significant difference in the survival ratio of NC101ΔibpAB between
WT and IL-10−/− macrophages, NC101 had a significantly lower survival ratio in IL-10−/−
versus WT macrophages. These data indicate that ibpAB expression impairs intracellular
survival of NC101 in macrophages, and that this effect is more pronounced in the absence of
IL-10. In addition, while NC101-infected WT and IL-10−/− macrophages secreted more TNF
during the first 3 hours of infection, they produced significantly less TNF from 3–24 hours
compared to NC101ΔibpAB-infected macrophages (Figure 5C). Thus, decreased long-term
intracellular survival of NC101 in macrophages compared to NC101ΔibpAB correlates with
reduced secretion of TNF at later time-points in vitro. Whether this effect occurs in intestinal
lamina propria macrophages in vivo and contributes to the decreased histologic
inflammation noted in NC101-monoassociated IL-10−/− mice remains to be determined.
DISCUSSION
To the best of our knowledge, this is the first published study of commensal bacterial gene
regulation in response to chronic, T-cell-mediated intestinal inflammation. We demonstrated
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that the E. coli stress response regulon, including the small heat shock proteins IbpAB, is
upregulated in the IL-10−/− mouse model of IBD. Contrary to our initial hypothesis, ibpAB
expression inhibits NC101 growth within the intestinal lumen and survival within primary
macrophages. This is evident from our studies using ibpAB-deficient E. coli NC101, which
showed enhanced luminal bacterial growth and inflammatory host responses in vivo, the
ability of ibpAB-deficient E. coli NC101 to outcompete parental NC101 in dual-association
studies, and increased bacterial survival within macrophages and elevated TNF secretion in
vitro. The reasons why bacteria would upregulate genes in response to inflammation that
decrease their survival in vivo are currently unclear.
The paradox could be explained by limitations of our experimental model. First, we are
studying E. coli in an un-natural, monoassociated system without the influences of other
commensal microbes, which could affect E. coli gene responses to intestinal inflammation.
Second, we have only studied gene expression levels in luminal bacteria whereas the results
from mucosally-associated bacteria may be quite different. Third, we inferred that ibpAB
expression in luminal E. coli is detrimental to the bacterium because its complete absence
resulted in increased growth. However, there could be a range of ibpAB expression levels,
below which fitness of the bacterium is inversely proportional to expression and above
which fitness is proportional to expression. Fourth, the complete absence of IbpAB may
cause alterations in expression of other genes, which in turn results in the observed
phenotype. However, we detected no differences in mRNA levels of genes adjacent to
ibpAB in NC101ΔibpAB compared to NC101 (data not shown).
While the functions of ibpAB in cultured bacteria are beginning to be elucidated, little is
known about their role in E. coli within the intestinal lumen. Others have shown that IbpAB
promote bacterial survival in vitro by functioning as molecular chaperones in conditions of
heat shock, enhancing resistance to oxidative stress, and facilitating biofilm
formation23, 29, 30. For example, oxidized proteins accumulate in ibpAB-deficient E. coli
exposed to copper ions, suggesting that ibpAB protects proteins from copper-induced
oxidative damage23. However, based on our results, we propose that E. coli ibpAB function
as negative survival factors in the colon, though the mechanisms by which this occurs are
unclear. We speculate that IbpAB preserve the function of proteins in certain metabolic
pathways that are less-efficient at extracting energy from dietary substances. This is
supported by evidence that ibpAB can protect metabolic enzymes from oxidative damage22.
Although we have shown that ibpAB are upregulated in luminal E.coli isolated from animals
with experimental colitis compared to healthy controls, the host-derived stimuli and their
cognate bacterial pathways that enhance ibpAB expression are unknown. In vitro studies
suggest that both ibpA and ibpB can be transcribed as an operon from a common promoter
that binds the alternative σ factor, σ32, whereas ibpB also can be independently transcribed
from a separate promoter located between the two genes, which binds σ54, a different
alternative σ factor, 31. Because we noted that both ibpA and ibpB were upregulated during
intestinal inflammation, the major stimulus is probably acting via σ32. However, since the
core temperature of the mice is probably minimally changed by colitis (though we did not
measure this), we doubt heat is causing increased ibpAB expression. More likely, the
inflamed intestine produces factors, such as reactive oxygen species, which cause unfolded
proteins to accumulate in the cytoplasm of luminal bacteria resulting in upregulation of σ32-
dependent ibpAB expression. Indeed, others have shown that reactive oxygen species are
increased in intestinal inflammation and that ibpAB protects E. coli from oxidative
damage7, 8, 21. Additional studies to identify the factors in the inflamed intestine that induce
ibpAB in luminal E. coli are needed.
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In summary, we show that a commensal E. coli strain upregulates a broad set of stress
response genes, particularly ibpAB, in response to intestinal inflammation in
monoassociated IL-10−/− mice. Furthermore, contrary to our original hypothesis, we provide
evidence that ibpAB expression in E. coli is associated with reduced survival of luminal and
intra-macrophage bacteria and increased host pro-inflammatory immune responses. These
data suggest that commensal intestinal microbes are not passive bystanders during intestinal
inflammation, but dynamically react to host-derived factors, even if it ultimately proves
detrimental to bacterial survival in the gut. Further studies of this important host-microbial
dialogue may provide clues to the pathogenesis of human IBD and potentially offer novel
therapeutic targets.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Spontaneous intestinal inflammation develops in E. coli NC101-monoassociated IL-10−/−
mice. WT and IL-10−/− mice were monoassociated with E. coli NC101 for 3 and 7 weeks.
Histological inflammation in the cecum (A) and spontaneous secretion of IL-12/23p40 from
proximal colon explant cultures (B) was measured. Data are means + SEM, n=5 mice/
group,*p<0.05 relative to WT.
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Survival of NC101 is attenuated relative to NC101ΔibpAB in vivo, but not in vitro. (A)
NC101 or NC101ΔibpAB were grown in LB under aerobic or anaerobic conditions and
bacterial density was measured using OD600. Data are presented as the mean+/−SEM, n=3
cultures/strain. (B) Luminal bacterial concentrations in monoassociated WT and IL-10−/−
mice. Data are means + SEM, n=5–6 mice/group, *p<0.05 relative to NC101-
monoassociated mice.
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Expression of E. coli ibpAB is associated with decreased inflammatory responses in NC101-
monoassociated IL-10−/− and WT mice. (A) Composite blinded histological inflammation
scores of 4 colonic segments from IL-10−/− or WT mice. (B) Representative
photomicrographs of cecum and mid-colon from IL-10−/− mice monoassociated for 5 weeks,
20x magnification. (C) Western blots of NC101 lysate using sera from 13 IL-10−/− mice
monoassociated with the indicated bacteria for 5 weeks. (D) Spontaneous secretion of
IL-12/23p40 in culture supernatants from proximal colon explants. (E) IFN-γ secretion by
unseparated MLN cells stimulated ex vivo with NC101 lysate. Data are means + SEM, n=5–
6 mice/group, *p<0.05 relative to NC101-monoassociated mice.
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Attenuated pro-inflammatory responses in IL-10−/− mice monoassociated with NC101
compared to NC101ΔibpAB are not proportional to differences in luminal bacterial
concentrations at early time points. Luminal bacterial concentrations in the cecum (A) or
mid-colon (B) from IL-10−/− mice monoassociated with NC101 or NC101ΔibpAB. (C)
Spontaneous IL-12/23p40 secretion in proximal colon explant cultures. (D) IFN-γ secretion
by unseparated MLN cells stimulated ex vivo with NC101 lysate. (E) Blinded composite
histological inflammation scores of 4 colonic segments. Data are means +/− SEM, n=5–6
mice/group, *p<0.05 relative to NC101-monoassociated mice.
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Expression of ibpAB by E. coli NC101 is associated with attenuated survival within
macrophages and decreased TNF secretion. (A) Intracellular survival of NC101 and
NC101ΔibpAB in WT and IL-10−/− bone marrow-derived macrophages. (B) Survival ratios
(24h/1h) of intracellular bacteria. (C) TNF secretion by NC101- or NC101ΔibpAB-infected
macrophages. Data are means + SEM, 3 wells/condition, representative of results from 3
different mice, *p<0.05 relative to NC101.
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Table 1
Selected genes upregulated in E. coli NC101 during experimental colitis.
Gene Fold Increase Description Alternative σ
ibpB 7.3 Heat shock protein 32,54
glpA 6.9 Glycerol-3-phosphate dehydrogenase, subunit A
cspH 6.2 Cold shock-like protein
glpC 5.3 Glycerol-3-phosphate dehydrogenase, subunit C
gadA 5.1 Glutamate decarboxylase beta, acid tolerance 38
ibpA 4.7 Heat shock protein 32
gadB 4.4 Glutamate decarboxylase beta, acid tolerance 38
oxyS 4.4 Global regulatory RNA, oxidative damage
ycfR 4.0 Hypothetical protein, biofilm formation
ydgF 3.6 Hypothetical protein, putative chaperone
hdeB 3.2 Hypothetical protein, acid resistance chaperone 38
glpD 3.1 Glycerol-3-phosphate dehydrogenase, subunit D
evgA 2.6 Positive transcription regulator of gadE
yhiX 2.3 Transcriptional regulator of gadE, gadB 38
inaA 1.8 pH-inducible protein involved in stress response
rpoH 1.6 RNA polymerase sigma-32 factor 38,54
hslV 1.5 ATP-dependent protease; heat shock protein 32
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